Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in High Risk Hemodialysis Patients
NCT04659525Phase 4Unknown
- Sponsor
- Policlinico Casilino
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in hypercholesterolemia, sponsored by Policlinico Casilino. Status: unknown.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04659525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659525.